Search Results - "Gutiérrez Valencia, Alicia"
-
1
SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
Published in Journal of clinical immunology (01-10-2021)Get full text
Journal Article -
2
HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors
Published in Biomedicine & pharmacotherapy (01-12-2023)“…Dual therapy (DT) has shown comparable results to triple therapy (TT) in efficacy and other immunological aspects. However, there are still some concerns about…”
Get full text
Journal Article -
3
Absolute CD4+ T cell count overstate immune recovery assessed by CD4+/CD8+ ratio in HIV-infected patients on treatment
Published in PloS one (22-10-2018)“…To analyse the correlation and concordance between aCD4, CD4%, CD4/CD8, their intra-patient variability, and to compare the immune recovery (IR) rates based on…”
Get full text
Journal Article -
4
Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
Published in Frontiers in immunology (15-03-2023)“…Data on SARS-CoV-2 mRNA vaccine immunogenicity in people living with human immunodeficiency virus (PLWH) and discordant immune response (DIR) are currently…”
Get full text
Journal Article -
5
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors
Published in Frontiers in immunology (18-10-2023)“…Background Interferon-inducible protein-10 (IP-10) and monokine induced by interferon-gamma (MIG) are chemokines recognized as inflammatory biomarkers during…”
Get full text
Journal Article -
6
Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial
Published in Stem cells translational medicine (01-04-2021)“…Between 15% and 30% of HIV‐infected subjects fail to increase their CD4+ T‐cell counts despite continuous viral suppression (immunological nonresponders…”
Get full text
Journal Article -
7
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy
Published in Pharmaceutics (30-11-2023)“…Outpatient parenteral antimicrobial therapy (OPAT) is a useful treatment strategy against and other multidrug-resistant bacteria. However, it is hindered by…”
Get full text
Journal Article -
8
-
9
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection
Published in Clinical infectious diseases (15-10-2007)“…Background. Transient elastometry (TE) is accurate for detecting significant liver fibrosis and cirrhosis in hepatitis C virus (HCV)–monoinfected patients…”
Get full text
Journal Article -
10
Point-of-care detection of SARS-CoV-2 antigen among symptomatic vs. asymptomatic persons: Testing for COVID-19 vs. infectivity
Published in Frontiers in public health (17-10-2022)“…Management of the coronavirus disease 2019 (COVID-19) pandemic caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requires rapid…”
Get full text
Journal Article -
11
Stability of Antimicrobials in Elastomeric Pumps: A Systematic Review
Published in Antibiotics (Basel) (30-12-2021)“…Outpatient parenteral antimicrobial therapy (OPAThttp) programs have become an important healthcare tool around the world. Portable elastomeric infusion pumps…”
Get full text
Journal Article -
12
Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy
Published in Antibiotics (Basel) (22-02-2023)“…Currently, ampicillin plus ceftriaxone (AC) is one of the preferred treatments for infective endocarditis. However, there is a lack of stability data for the…”
Get full text
Journal Article -
13
PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors
Published in ACS applied bio materials (21-06-2021)“…Hepatocellular carcinoma (HCC) is the sixth most common neoplasia and the fourth most common cause of cancer-related mortality worldwide. Sorafenib is the…”
Get full text
Journal Article -
14
Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives
Published in Antibiotics (Basel) (30-09-2020)“…The selection of the best alternative for infective endocarditis (IE) continuation treatment in the outpatient setting is still challenging. Three databases…”
Get full text
Journal Article -
15
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
Published in Clinical infectious diseases (15-10-2009)“…Background. The aim of this study was to assess the efficacy and safety of pegylated interferon (IFN) plus ribavirin (RBV) in human immunodeficiency virus…”
Get full text
Journal Article -
16
Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice
Published in Journal of acquired immune deficiency syndromes (1999) (01-05-2019)“…BACKGROUND:Various recent outbreaks of hepatitis A virus (HAV) have been described in men who have sex with men despite the availability of an effective…”
Get full text
Journal Article -
17
Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events: A Randomized Trial
Published in Annals of internal medicine (04-08-2009)“…More than 50% of patients who start efavirenz treatment develop limiting neuropsychiatric adverse events (NPAEs). To assess whether stepwise dosing of…”
Get full text
Journal Article -
18
Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
Published in Journal of the International AIDS Society (01-02-2018)“…Introduction When darunavir (DRV) 800 mg is boosted with 150 mg cobicistat (DRVcobi), DRV trough concentration (Ctrough) is about 30% lower as compared to…”
Get full text
Journal Article -
19
Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients
Published in Journal of antimicrobial chemotherapy (01-03-2012)“…Objectives To compare intracellular and plasma etravirine concentrations when etravirine was given at 200 mg/12 h versus 400 mg/24 h and to evaluate whether…”
Get full text
Journal Article -
20
Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?
Published in AIDS (London) (01-03-2023)Get full text
Journal Article